These findings indicated that Rac1 inhibition affected MM cell proliferation regardless of the p53 status, consistent with a report on lymphoma suggesting that Rac1 targeting may affect cell growth independent of the p53 status [10]. This evidence concerns the gene TP53 and Miyoshi myopathy.